Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05814367 · ClinicalTrials.gov registry record · Phase 2
Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops
A Phase 2 study, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- Phase 2
- Development phase
- 46
- Enrollment target
NCT05814367 is a Phase 2 study that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 46 participants.
The verdict
NCT05814367, a Phase 2 study, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 46 participants
- Enrollment target
Study Summary
This will be a single-visit, multi-site, randomized, single-masked, bilateral, active-controlled, non-dispensing, 2X2 crossover study.
Interventions
- DRUG Blink® Tears eye drops in a multidose bottle
- DRUG Preservative-free investigational lubricating eye drops in a Novelia® eyedropper
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2023-04-06 |
| Est. Completion | 2023-05-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05814367
The ClinicalTrials.gov registry entry for NCT05814367 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Blink® Tears eye drops in a multidose bottle is the first listed.
NCT05814367 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05814367 about?
NCT05814367 is a clinical study titled "Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of Investigational Lubricating Eye Drops". This will be a single-visit, multi-site, randomized, single-masked, bilateral, active-controlled, non-dispensing, 2X2 crossover study.
What is the current status of trial NCT05814367?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 2023-04-06. Estimated completion is 2023-05-06.
What interventions are being tested in trial NCT05814367?
The interventions under investigation include: Blink® Tears eye drops in a multidose bottle (DRUG), Preservative-free investigational lubricating eye drops in a Novelia® eyedropper (DRUG).
Who is sponsoring clinical trial NCT05814367?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.